PHqghUme PHqghUme
Fatty Liver and Type 2 Diabetes? Try a Weekly Injection Study
About The Study
This study is for adults diagnosed with Type 2 Diabetes and fatty liver disease caused by MASH, sometimes called “fatty liver.” It focuses on people with liver cirrhosis due to MASH and aims to test the safety and effectiveness of a once-weekly injection of an investigational medication as a potential treatment.
To take part in the study, participants should be:
- Diagnosed with MASH (or ‘Fatty Liver’) Cirrhosis.
- Willing to have a liver biopsy performed.
- BMI greater than 27
- A1c less than 10%.
